Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Trending Stock Alerts

FLDM Stock - Fluidigm Corporation Stock Trading


home / stock / fldm

FLDM FLDM Quote FLDM Short FLDM News FLDM Articles FLDM Message Board

MWN AI Summary *

Fluidigm Corporation (NASDAQ: FLDM) is a biotechnology company focused on enabling the advancement of life sciences research and personalized medicine through its innovative technology platforms. Founded in 1999 and headquartered in South San Francisco, California, Fluidigm specializes in providing solutions for genomic research, single-cell analyses, and mass cytometry. Its products are designed to facilitate high-throughput, high-resolution analysis of biological samples, catering to the needs of researchers across various sectors, including academic institutions, hospitals, and pharmaceutical companies.

One of Fluidigm's flagship products is the Biomark platform, which allows researchers to perform digital PCR and multiplex gene expression analysis, delivering rapid and precise results. Additionally, the company offers the CyTOF technology, which provides deep, quantitative analysis of protein expression in single cells, paving the way for groundbreaking discoveries in immunology and oncology.

Over recent years, Fluidigm has made significant strides in addressing key challenges in research and diagnostics, particularly in the fields of cancer, immunology, and infectious diseases. The company's commitment to innovation is evident in its ongoing development of new assays and platforms, as well as collaborations with leading academic and industry partners.

Despite facing challenges such as market competition and financial volatility, Fluidigm continues to pursue growth through strategic investments and product enhancements. As of October 2023, the company has positioned itself as a vital player in the biotechnology space, with strong potential for future developments in personalized medicine and therapeutics.

Investors and analysts remain watchful of Fluidigm’s financial performance and market positioning, particularly amid evolving landscape dynamics in the life sciences sector. The ongoing demand for advanced research tools and applications, particularly in the wake of global health challenges, underlines Fluidigm's importance in the biotechnology ecosystem.

MWN AI Analysis *

As of October 2023, Fluidigm Corporation (NASDAQ: FLDM) presents an intriguing investment opportunity amid a volatile biotech market landscape. The company, known for its innovative tools in single-cell biology, genomics, and proteomics, has historically shown growth potential due to its cutting-edge technology and unique product offerings.

Recent financial performance indicates a mixed outlook. While Fluidigm has successfully maintained a focus on strategic partnerships and acquisitions to enhance its product portfolio, revenue performance over the past quarters has been somewhat inconsistent. The company reported a slight year-over-year revenue decline in its most recent earnings release, primarily due to shifting market dynamics and increased competition in the life sciences sector. Investors should be attentive to trends in funding for research and development, as these can be strong indicators of future revenue.

From a valuation perspective, Fluidigm's current price-to-sales ratio is higher than the industry average, which suggests that the stock may be overvalued relative to its earnings potential. However, considering the long-term growth prospects in single-cell analysis and personalized medicine, a high valuation could be justified if the company successfully translates its innovative technology into robust sales growth.

For potential investors, a prudent approach could involve dollar-cost averaging to mitigate short-term volatility while waiting for operational improvements and expanding market acceptance of Fluidigm's products. Additionally, keeping a close eye on regulatory approvals and strategic collaborations will be crucial for gauging the company’s trajectory.

In summary, while Fluidigm Corporation presents inherent risks, strategic positioning in a growing market provides a case for long-term investment consideration. Investors should remain cautious yet optimistic, keeping abreast of market developments that could impact the company's financial health moving forward.

* MWN AI Summary and Analysis is based on asking OpenAI to summarize and analyze the company and stock symbol.


About | Fluidigm Corporation (NASDAQ:FLDM)

Not available

Quote | Fluidigm Corporation (NASDAQ:FLDM)

Last:$3.71
Change Percent: -7.02%
Open:$4.05
Close:$3.71
High:$4.05
Low:$3.66
Volume:526,846
Last Trade Date Time:04/05/2022 04:54:08 pm

News | Fluidigm Corporation (NASDAQ:FLDM)

  • Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

    Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating Structure and Enables Achievement of A...

    • June 23, 2025 07:05:18 am

    • |
    • GlobeNewswire
    • |
      • FLDM Stock
      • FLDM Quote
      • FLDM Short
      • FLDM News
      • FLDM Articles
      • FLDM Message Board
  • Standard BioTools to Host Inaugural "Proteomics Roundtable" Webcast Series

    SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of its inaugural Proteomics Roundtable Series – a program of virtual events designed to spark conversation about the rapidly evolving field of proteomics. The s...

    • May 30, 2025 07:00:00 am

    • |
    • GlobeNewswire
    • |
      • FLDM Stock
      • FLDM Quote
      • FLDM Short
      • FLDM News
      • FLDM Articles
      • FLDM Message Board

Message Board Posts | Fluidigm Corporation (NASDAQ:FLDM)

Subject By Source When
$FLDM bot this 30 min chart today.. manysevens investorshub 11/25/2021 2:35:03 AM
No. I think they are in deep doo Eggplant investorshub 11/08/2021 10:36:44 PM
$FLDM Back from the dead? LongTimeObserver investorshub 11/06/2020 7:08:34 PM
Pffft! $FLDM LongTimeObserver investorshub 10/29/2020 4:02:59 PM
06:28 $FLDM Fluidigm: Trump Administration provides saliva test at surge Atlanta1 investorshub 10/19/2020 12:27:10 PM

MWN AI FAQ **

What recent financial performance trends have been observed for Fluidigm Corporation (NASDAQ: FLDM) and how might these affect investor sentiment moving forward?

Recent financial trends for Fluidigm Corporation (NASDAQ: FLDM) indicate fluctuating revenues and mounting losses, which may lead to cautious investor sentiment as uncertainties about profitability and market positioning continue to loom.

How do the latest product developments and innovations from Fluidigm Corporation FLDM position the company against its competitors in the biotech industry?

Fluidigm Corporation's latest innovations, particularly in single-cell genomics and comprehensive multiplexing capabilities, enhance its competitive edge in the biotech industry by enabling more precise and scalable research solutions compared to its rivals.

What are the key risks and opportunities facing Fluidigm Corporation (NASDAQ: FLDM) in the current market environment and how should investors gauge these factors?

Key risks for Fluidigm Corporation include competition and regulatory challenges, while opportunities lie in advancing its biomarker technology and market expansion; investors should closely monitor quarterly performance, technological developments, and market trends to gauge these factors.

How is Fluidigm Corporation FLDM managing its operational costs amidst economic challenges, and what impact could this have on its profitability and stock performance?

Fluidigm Corporation is implementing cost-cutting measures and operational efficiency initiatives to manage its expenses amid economic challenges, which could enhance profitability and positively influence its stock performance if sustained.

** MWN AI Questions are based on asking OpenAI to ask and answer four questions about the company and stock symbol.

Stock Information

Get FLDM Alerts

News, Short Squeeze, Breakout and More Instantly...

Fluidigm Corporation Company Name:

FLDM Stock Symbol:

NASDAQ Market:

-7.02% G/L:

$3.71 Last:

526,846 Volume:

$4.05 Open:

$3.71 Close:

Fluidigm Corporation Website:

Fluidigm Corporation Logo

Ad

Trending Stock Alerts
RECENT FLDM NEWS
  • FLDM - Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

    Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating Structure and Enables Achievement of A...

  • FLDM - Standard BioTools to Host Inaugural "Proteomics Roundtable" Webcast Series

    SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of its inaugural Proteomics Roundtable Series – a program of virtual events designed to spark conversation about the rapidly evolving field of proteomics. The s...

  • FLDM - Standard BioTools Reports First Quarter 2025 Financial Results

    SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the first quarter ended March 31, 2025. Recent Highlights: First quarter...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Connect with Us

Join our Telegram Alerts Channel

Telegram

Join our Discord

Discord

Get FLDM Alerts

Get FLDM Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1